Condition: Rhinovirus Infection · Sponsor: Altesa Biosciences, Inc.
Compare the safety and efficacy of two different oral vapendavir doses with placebo in order to determine the appropriate dose of vapendavir to reduce the severity and/or duration of respiratory symptoms associated with RV infections in patients with COPD.
This description comes directly from the study's public registry record.
Karen Fusaro · 610-242-0903 · kfusaro@altesa.com
Always discuss trial participation with your own doctor first.
| AMR Clinical - Tempe | Tempe, Arizona, United States | Recruiting |
| NewportNativeMD, Inc. | Newport Beach, California, United States | Recruiting |
| Apex Clinical Research | San Diego, California, United States | Recruiting |
| VM Clintrials | Miami Lakes, Florida, United States | Recruiting |
| Accelerated Clinical Trials, LLC | Snellville, Georgia, United States | Recruiting |
| Velocity Clinical Research - Valparaiso | Valparaiso, Indiana, United States | Recruiting |
| Patient First Clinical Trials (PFCTRIALS) | Lutherville, Maryland, United States | Recruiting |
| Brooklyn Clinical Research | Brooklyn, New York, United States | Recruiting |
| CRC Kings Mountain | Kings Mountain, North Carolina, United States | Recruiting |
| Remington-Davis, Inc. | Columbus, Ohio, United States | Recruiting |
| Clinical Research Associates of Central PA, LLC | DuBois, Pennsylvania, United States | Recruiting |
| Preferred Primary Care Physicians - St. Clair | Pittsburgh, Pennsylvania, United States | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07610395